GlassScriptPhysician profile
Susan Mccloskey
NPI 1811560030
$1,921.19
in general payments reported to CMS, 2019-2025
18 companies · $808 in 2025
The $808 reported for 2025 was more than what 76% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.85 · 2023: $430 · 2024: $663 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $457.03 | 2023-2025 | Ingrezza |
| Abbvie INC. | $359.60 | 2023-2025 | |
| Alkermes, INC. | $201.98 | 2022-2024 | Lybalvi, Aristada, Vivitrol |
| Axsome Therapeutics, INC. | $170.27 | 2023-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $105.72 | 2024-2025 | Qelbree |
| E.R. Squibb & Sons, L.L.C. | $104.12 | 2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $95.92 | 2025 | Fanapt |
| Indivior INC. | $84.01 | 2024-2025 | Sublocade |
| Otsuka America Pharmaceutical, INC. | $80.18 | 2024-2025 | Abilify Maintena |
| Ironshore Pharmaceuticals INC. | $69.33 | 2024 | |
| Corium, LLC | $46.94 | 2024 | Azstarys |
| Globus Medical, INC. | $30.17 | 2025 | Senza |
| Novo Nordisk INC | $23.12 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $20.33 | 2024 | Uzedy |
| Xeris Pharmaceuticals, INC. | $20.18 | 2024 | Gvoke Hypopen |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.50 | 2024 | Spravato |
| Braeburn INC. | $17.09 | 2024 | Brixadi |
| Collegium Pharmaceutical, INC. | $16.70 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Mccloskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.